Background: Influenza-associated myositis (IAM) is a rare and poorly recognized complication of influenza infection in children, and is characterized by acute onset of severe pain in the lower extremities and a refusal to ambulate walk. We sought to understand the association between IAM and influenza B infection and to investigate its clinical and laboratory characteristics in affected children. Methods: Influenza B-associated myositis (IBAM) cases diagnosed in the pediatrics department of Wonkwang University Hospital from January 2010 and March 2016 were analyzed retrospectively. Results: Medical records of affected children were examined, and clinical characteristics and laboratory findings were recorded. Of the 536 children diagnosed with influenza B infection, 47 children complained of bilateral calf pain with or without gait disturbance. All children exhibited elevated serum aspartate aminotransferase (AST) level. The median serum creatine kinase (CK) and lactate dehydrogenase (LDH) levels, reportedly elevated in myositis, were 2,597 IU/L and 678 IU/L, respectively. While the immunofluorescence test results were negative for some patients, the polymerase chain reaction test results indicated influenza B infection in all 47 children. At the time of hospital discharge, the patients' symptoms had resolved, and their CK levels had improved. Conclusion: IBAM was generally benign and short, and although the blood AST, CK, and LDH levels were markedly high, the erythrocyte sedimentation rate and C-reactive protein levels were normal. Further, the duration of IBAM symptoms correlated with the duration of fever. The IBAM-associated clinical and laboratory findings are highly characteristic and may allow its rapid diagnosis during the influenza season.
INTROduCTION
Influenza is common and usually benign viral respiratory tract infection caused by the influenza virus, and annual influenza epidemics occur worldwide during the cold season.
1) The infections typically begin with predominantly systemic symptoms that include fever, chills, headache, myalgia, malaise, and anorexia. 2, 3) Influenza is associated with a variety of complications 4) that primarily affect the respiratory tract and the central nervous system. Influenza-associated myositis (IAM), another complication of the infection, has only been reported sporadically since its first description in 1957. 5) Although IAM is more common in children than in adults, its age-specific incidence during influenza epidemics is unknown. IAM is a generally benign, self-limiting condition that usually affects boys and manifests as calf tenderness, and sudden onset of difficulty in walking after an influenza infection. 6) However, IAM may not be easily distinguishable from other diseases, and therefore, children may undergo unnecessary diagnostic testing and treatment. In addition, several IAM cases with a severe course and life-threatening complications have been also reported. 7) IAM is typically associated with the Influenzavirus B, and previous reports demonstrate that influenza B infections cause myositis more often than influenza A infections. Although specific pathophysiology of IAM has not been established, the greater potency of Influenzavirus B to directly invade muscle cells may result in greater muscle cell damage, and may be one explanation for the pathophysiological difference observed between influenza A and B infections. 8) Few previous studies have investigated IAM in childhood; however, the number of investigated cases was small in each of these studies.
Further, no previous study has assessed the progression rate of myositis through an evaluation of laboratory findings and clinical symptoms like fever. Therefore, in our study, we aimed to assess the correlation between myositis progression and patients' laboratory findings and clinical symptoms. In addition, we studied the laboratory findings and clinical characteristics of influenza B-associated myositis patients in order to differentiate it from other severe myositis-inducing diseases and avoid unnecessary examinations.
METhOdS
We retrospectively analyzed IBAM cases diagnosed in the pediatrics department of Wonkwang University Hospital from January 2010 to December 2015. The inclusion criteria for IBAM cases were as follows:
(1) acute onset; (2) presence of calf muscle tenderness with or without a gait disturbance; (3) confirmed influenza B viral infection; (4) increased serum creatine kinase (CK) level; and (5) a self-limiting disease course. We performed chart reviews to collect data on clinical manifestations, age and sex of the patients, the duration of hospitaliza- (Table 1) .
RESuLTS

Influenza
During the same period, a total of 59 children complained of severe bilateral calf pain. Of them, 47 children tested positive for Influenzavirus B; four children tested positive for Adenovirus; and five children tested positive for Influenzavirus A, while no viral infection was detected in three children ( Figure 1 ). The median age of 47 influenza B-infected children was 6.8 years. The median duration of fever was 3.8 days, the median duration from onset of fever to the onset of calf pain was 2.1 days, and the median duration from the onset of calf pain to the im- None of the 47 children had any other influenza-related complications such as otitis media, pneumonia, myocarditis. At the time of discharge from the hospital, the children's presenting symptoms had resolved, and their CK levels had improved.
dISCuSSION
The influenza infections predominant throughout Korea during the winter season cause highly contagious acute respiratory infections.
1)
Fever is the most characteristic symptom associated with an influenza infection, although general symptoms such as a headache, myalgia, fatigue, and sore throat; and respiratory symptoms such as a cough, excessive sputum production, and coryza may also be associated with the infection. In addition, abdominal pain, nausea, and vomiting are also reported occasionally. Although most patients recover in approximately 1 week, death may occur in influenza-infected patients with chronic pulmonary diseases, heart diseases, or immunodeficiency-related diseases due to complications like pneumonia. Patients may also experience other complications such as encephalopathy, myelitis,
Reye's syndrome, myositis, cardiomyositis, and pericarditis. [1] [2] [3] [4] [5] 8) Symptoms of influenza complications linked to the musculature vary widely, from simple muscle pain to rhabdomyolysis. 6,7,9) IAM causes acute pain and muscular spasms during the recovery phase of the influenza infection, after the onset of respiratory symptoms. The IAM symptoms usually resolve within 3-10 days, and IAM thus has a good overall prognosis. Values are mean±standard deviation (range) or number (%). 16) In a small number of published pathological investigations, isolated segmental muscle fiber degeneration and necrosis without flanking myositis were noted, supporting the hypothesis of influenza virus-mediated direct muscle cell damage. [17] [18] [19] [20] IBAM affects children and is predominately noted in boys aged 3-14 years. 21, 22) This male predominance may reflect a genetic predisposition or as yet unidentified metabolic defects. 11, 21) The IBAM-associated myalgia appears abruptly, and may be severe, leading to gait disturbances or refusal to ambulate that may last for several days. Muscle swelling and tenderness may also occur in some cases.
In our study, the median age of IBAM onset among the 47 study subjects was 6.8 years, and the median duration from the onset of influenza symptoms to the onset of muscular symptoms was 2.1 days. In his study, Lundberg 5) reported the median age of onset as 9 years, while Mackay et al., 21) Bove et al., 23) and Agyeman et al. 8) reported median onset age as 8.1 years, 7 years, and 8.5 years, respectively. The median onset age in our study group was thus lower than that reported previously. The above-mentioned studies also reported the median duration between the onset of influenza symptoms and the onset of muscular symptoms as 2.6 days, 5 days, 5 days, and 3 days, respectively. In the 47 children in our study, and the IBAM-associated myalgia resolved after a median duration of 4.2 days, similar to the duration reported in the literature. 5, 8, 21) Our laboratory findings, including the significant increase in blood CK, AST, and LDH levels, matched previously published reports. 21, 22) However, leukopenia and thrombocytopenia were not commonly noted in our study subjects; only 9 of the 47 children exhibited leukopenia, while eight children exhibited thrombocytopenia.
It is important to distinguish IBAM from more serious causes of gait disturbance and refusal to walk, such as influenza-associated myalgia, The use of imaging modalities, such as magnetic resonance imaging (MRI), has been described in the diagnosis of IBAM; however, an MRI may be more appropriate for the exclusion of other causes of myositis. 28, 29) The hallmark of IBAM is its spontaneous and rapid clinical resolution within a week of symptom onset. 21) Treatment is supportive, and antiviral drugs are unlikely to be beneficial when started after the acute onset of viral infection; moreover, their benefit in cases of severe influenza, when administered after more than 2 days of symptom onset, is uncertain.
2)
The association between vaccination against influenza and the risk of developing IBAM is unknown. Our study did not assess the influen- This study has some limitations. We relied on a retrospective study design, with a small number of patients, in a specific area, at a single center. To assess the association between IBAM duration and laboratory findings, further multicenter studies with larger sample size are needed.
In conclusion, IBAM patients showed a benign disease course with abrupt symptom onset, usually affecting the lower extremities, and a short disease duration, in addition to the symptoms of influenza.
These clinical characteristics may aid differential diagnosis in children with myalgia during influenza B epidemics and may help avoid unnecessary testing procedures. Although the blood AST, CK, and LDH levels were markedly increased in our study population, the ESR, and the CRP levels were normal. Moreover, even as the CK, AST, and ALT levels were not associated with the duration of IBAM symptoms, the duration of fever was associated with the duration of symptoms.
Therefore, even though it may be difficult to predict disease progression on the basis of laboratory findings, the duration of fever may be considered predictive of the disease progression.
